PROGRESS - Subcutaneous PROgesterone in fRozen-thawed single Euploid blaStocyst tranSfer
Research payments
$15,651,504
Through program year 2025, $15,651,504 in research payments was reported against PROGRESS - Subcutaneous PROgesterone in fRozen-thawed single Euploid blaStocyst tranSfer, across 367 payments, paid by IBSA Institut Biochimique SA.
- Paid by
- IBSA Institut Biochimique SA
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $7,693,110 | 112 |
| 2024 | Research | $6,928,374 | 189 |
| 2023 | Research | $1,030,020 | 66 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- John Park Raleigh, NC Named on 19 payments
- Vicky Schnell Webster, TX Named on 18 payments
- Ronald Feinberg Newark, DE Named on 18 payments
- Kevin Doody Bedford, TX Named on 16 payments
- Shawn Gurtcheff Pleasant Grove, UT Named on 14 payments
- Harry Craig Tempe, AZ Named on 12 payments
- Mark Sanchez Clearwater, FL Named on 12 payments
- Mark Leondires Norwalk, CT Named on 12 payments
- LUIS HOYOS Martinez Pembroke Pines, FL Named on 11 payments
- Laurel Stadtmauer Winter Park, FL Named on 11 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.